Learning from FDA Warning Letters – OOS’s and aborted HPLC runs
FDA Warning Letters as a Compliance Benchmarking Tool FDA Warning letters are a valuable resource to learn the Agency’s expectations around specific practices. FDA publishes these regularly on their website. Many of these Warning Letters items issued for critical GMP non-compliances have data integrity implications. Let’s analyze one such GMP non-compliance issue from December 2017…
Read more